Mailleroncourt-Charette, France

Emmanuelle Remond


Average Co-Inventor Count = 5.6

ph-index = 1


Company Filing History:


Years Active: 2015-2017

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Emmanuelle Remond: Innovator in Organophosphorus Compounds

Introduction

Emmanuelle Remond is a distinguished inventor based in Mailleroncourt-Charette, France. She has made significant contributions to the field of chemistry, particularly in the development of organophosphorus compounds. With a total of three patents to her name, her work has implications in various applications, including agrochemicals and therapeutic substances.

Latest Patents

One of her latest patents focuses on P-chirogenic organophosphorus compounds, detailing a process for their synthesis. These compounds, represented by a general formula, are essential in the creation of metal complexes that serve as ligands. The applications of these compounds extend to asymmetric catalysis, particularly in processes like asymmetric hydrogenation and allylation. Another notable patent involves the versatile and stereospecific synthesis of γ,δ-unsaturated amino acids through a Wittig reaction. This patent also outlines intermediate products that play a crucial role in the synthesis of these amino acids.

Career Highlights

Emmanuelle has worked with prominent institutions such as the Centre National de la Recherche Scientifique and the Université de Bourgogne. Her research has not only advanced the field of chemistry but has also paved the way for innovative applications in various industries.

Collaborations

Throughout her career, Emmanuelle has collaborated with notable colleagues, including Sylvain Juge and Jerome Bayardon. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Emmanuelle Remond's innovative work in organophosphorus compounds showcases her expertise and dedication to advancing chemical research. Her patents reflect her commitment to developing useful applications in both agrochemicals and therapeutic fields.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…